A recent study in ClinicoEconomics and Outcomes Research found that community pharmacists can provide high-quality, cost-effective care for minor ailments, reducing the financial burden on the healthcare system compared to primary care physicians, urgent care, and emergency departments.
Intellia’s gene editing therapy succeeds in Phase 2 genetic swelling condition study
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
August 9, 2024